Also known as: 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, 5-26-13-00558, Anhydrous caffeine, BRN 0017705, Cafamil (+14 more)
INCI: CAFFEINE
Caffeine (CAS 58-08-2) is a cosmetic active ingredient functioning as active / lipolytic / antioxidant. NOAEL 206.2 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: permitted, max 6% leave-on body, 1.5% eye lotions, 2% face powder. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety, pharmaceutical, and food safety data.
EU Max Conc.6% leave-on body, 1.5% eye lotions, 2% face powder
US US Statuspermitted
US NotesFDA permits in cosmetics without restriction — no pre-approval required. GRAS as food additive in cola beverages ≤0.02% (21 CFR 182.1180). Approved OTC stimulant drug (100–200 mg oral). NOT a GRASE sunscreen active — not listed in FDA sunscreen monograph; only zinc oxide and titanium dioxide hold full GRASE status for UV protection. MoCRA: no specific caffeine designation.
For full compliance data across multiple jurisdictions, use the
Substance Compliance tool.
Safety Data
Margin of Safety, dermal absorption, and sensitization profile summaries for Caffeine.
Calculate MoS for your specific formulation with the
MoS Calculator.
Toxicological Studies
10 study endpoints found for Caffeine. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
Endpoint
Value
Route
Species
Study Type
Source
NOAEL
3 mg/kg bw/day
oral
rat
Neurotoxicity
COSMOS DB
NOAEL
6 mg/kg bw/day
oral
rat
Developmental
COSMOS DB
NOAEL
10 mg/kg bw/day
oral
rat
Special Toxicology Study
COSMOS DB
NOAEL
12.5 mg/kg bw/day
oral
monkey
Multigeneration Reproductive
COSMOS DB
NOAEL
13 mg/kg bw/day
oral
monkey
Reproductive
COSMOS DB
NOAEL
15 mg/kg bw/day
oral
rat
Neurotoxicity
COSMOS DB
NOAEL
20 mg/kg bw/day
oral
rat
Neurotoxicity
COSMOS DB
NOAEL
22.5 mg/kg bw/day
oral
rat
Developmental
COSMOS DB
NOAEL
24.7 mg/kg bw/day
oral
rat
Developmental
COSMOS DB
NOAEL
25 mg/kg bw/day
oral
rat
Developmental
COSMOS DB
GHS Hazard Classification
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Short-term Exposure Effects
The substance may cause effects on the central nervous system and cardiovascular system. This may result in insomnia, excitement, tachycardia and polyuria.
Routes of Exposure
The substance can be absorbed into the body by inhalation and by ingestion.
Pre-Calculated Safety Assessment
Pre-calculated NOAEL → SED → MoS audit trail for Caffeine across SCCS product categories, with measured dermal absorption where available.
Dermal Penetration Profile
Skin absorption and penetration characteristics of Caffeine, relevant to systemic exposure and MoS calculations.
Absorption %
15-30%
Penetration Level
epidermis
Penetration Depth
epidermis/dermis
Molecular Weight
194.2 Da
Log P
-0.07
Systemic Absorption
yes
Topical Bioavailability
10-25%
Safety Margin Factor
high
Vehicle Dependent
Yes — absorption varies by formulation
Source: Skin Pharmacol Physiol 2007
EPA ToxValDB — Toxicity Values
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
Endpoint
Value
Species
Route
Duration
Source
LC50
~4940 mg/m3
Rat
inhalation
-
ECHA
LD50
>2000 mg/kg
Rat
dermal
acute
ECHA
LD50
=367.7 mg/kg
Rat
oral
-
ECHA
LD50
=185 mg/kg
Mouse
oral
-
ECHA
LD50
>=200 mg/kg
Rat
oral
-
ECHA
LD50
<=400 mg/kg
Rat
oral
-
ECHA
LEL
=220 mg/kg-day
Rat
oral
-
ECHA
LEL
=240 mg/kg-day
Rat
oral
-
ECHA
LEL
~35 mg/kg-day
Mouse
oral
-
ECHA
LOEL
=20 mg/kg-day
Rat
oral
short-term
ECOTOX
IARC Carcinogenicity
International Agency for Research on Cancer (WHO) monograph evaluation.
IARC Group
3
Volume
51
Evaluation Year
1990
EU CLP Annex VI Harmonized Classification
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Signal Word
Warning
Pictograms
Harmful / Irritant
Hazard Class and Category
Acute Tox. 4 *
Hazard Statements
H302Harmful if swallowed
Inserted via ATP: CLP00
ECHA REACH Registration
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Registration Type
Full
Tonnage Band
1,000 - 10,000 tonnes
Substance Type
SUBSTANCE; GROUP
SVHC Candidate
No
Hazard classification:Restricted (Annex XVII)
Expanded Dermal Absorption Data
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
EPA Dryad Skin Absorption (physics-based)
MW:194.194
LogP:-0.0709947
Kp epidermis:0.00248 cm/h
% dose epidermis:0.97%
% dose stratum corneum:0.96%
% dose dermis:0.94%
Source: EPA Dryad Skin Absorption 2024
Roberts Skin Permeation (Mendeley 2022)
MW:194.19
Log Kow:-0.63
Log Kp:-3.6556077263148894
Log Jmax:-7.418237303551122
Source: Roberts Cheruvu Mendeley 2022
Aggregated DA Values (1 records across 5 sources)
Type
DA %
Method
Skin Model
SCCS Ref
measured_in_vitro
0.09-0.39
In vitro; OECD TG 428 ring trial (GLP, 6 labs); Nitsche 2004
Human split-thickness skin
Regul Toxicol Pharmacol 2022; Nitsche 2004 (2022)
Typical Use Concentrations
Reported concentration ranges per product category from SCCS/CIR/industry sources.
Product Category
Typical Range
Max Reported
Source
Eye Cream
0.5–3
5
CIR Safety Assessment
Serum
1–5
5
CIR Safety Assessment
Function Categories & List Membership
Cosmetic/Chemical Function Categories
BiocideDeodorizerFlavouring and nutrientFragrancePharmaceuticalSoftener and conditioner
Regulatory List Membership (1)
FDA Substances Added to Food (EAFUS)
Editorial summary
Preliminary editorial summary for Caffeine — not a computed safety verdict. See the sourced toxicological data above.
Caffeine has a safety rating of "GOOD" in our database. EU status: permitted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Is Caffeine allowed in the EU?
Caffeine EU regulatory status: permitted. Maximum allowed concentration: 6% leave-on body, 1.5% eye lotions, 2% face powder. This is based on EU Regulation 1223/2009 and its amendments.
What does Caffeine do in cosmetics?
Caffeine functions as: active / lipolytic / antioxidant. It is classified as a Active Ingredient in our database. CAS number: 58-08-2.
What is the NOAEL for Caffeine?
The NOAEL (No Observed Adverse Effect Level) for Caffeine is 3 mg/kg bw/day based on a Neurotoxicity study via oral route in rat. A total of 10 study endpoints are available. Source: COSMOS DB.
Is Caffeine used outside cosmetics?
Caffeine also appears in industrial chemical safety, pharmaceutical, and food safety data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Compliance Tools
Check Caffeine compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.